ATE128452T1 - S(+)-ibuprofen-l-aminosäure und s(+)-ibuprofen-d- aminosäure als analgetika mit grösserem pharmakologischem potential. - Google Patents

S(+)-ibuprofen-l-aminosäure und s(+)-ibuprofen-d- aminosäure als analgetika mit grösserem pharmakologischem potential.

Info

Publication number
ATE128452T1
ATE128452T1 AT90311150T AT90311150T ATE128452T1 AT E128452 T1 ATE128452 T1 AT E128452T1 AT 90311150 T AT90311150 T AT 90311150T AT 90311150 T AT90311150 T AT 90311150T AT E128452 T1 ATE128452 T1 AT E128452T1
Authority
AT
Austria
Prior art keywords
ibuprofen
amino acid
analgesics
greater pharmacological
pharmacological potential
Prior art date
Application number
AT90311150T
Other languages
English (en)
Inventor
King Chiu Kwan
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE128452T1 publication Critical patent/ATE128452T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/08Saturated compounds having a carboxyl group bound to a six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT90311150T 1989-10-17 1990-10-11 S(+)-ibuprofen-l-aminosäure und s(+)-ibuprofen-d- aminosäure als analgetika mit grösserem pharmakologischem potential. ATE128452T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42246689A 1989-10-17 1989-10-17

Publications (1)

Publication Number Publication Date
ATE128452T1 true ATE128452T1 (de) 1995-10-15

Family

ID=23675012

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90311150T ATE128452T1 (de) 1989-10-17 1990-10-11 S(+)-ibuprofen-l-aminosäure und s(+)-ibuprofen-d- aminosäure als analgetika mit grösserem pharmakologischem potential.

Country Status (10)

Country Link
EP (1) EP0424028B1 (de)
JP (1) JPH03206064A (de)
KR (1) KR910007858A (de)
AT (1) ATE128452T1 (de)
AU (1) AU635074B2 (de)
CA (1) CA2027624A1 (de)
DE (1) DE69022678T2 (de)
DK (1) DK0424028T3 (de)
IE (1) IE68508B1 (de)
PT (1) PT95564B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT59656A (en) * 1990-11-15 1992-06-29 Puetter Medice Chem Pharm Process for producing s/+/-phenyl-alkanoic acids and alpha-amino-acids containing complexes and pharmaceutical compositions containing them as active components
HUT59653A (en) * 1990-11-15 1992-06-29 Puetter Medice Chem Pharm Process for producing complexes containing s/+/-phenyl-alcanoic acids and alpha-hydroxy-alcanoic acids and pharmaceutical compositions containing them as active components
US5552160A (en) * 1991-01-25 1996-09-03 Nanosystems L.L.C. Surface modified NSAID nanoparticles
GB9200114D0 (en) * 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase
FR2687673B1 (fr) * 1992-01-13 1995-07-07 Jung Jean Sels amines d'acides arylcarboxyliques, sterilisables, solubles dans l'eau, utilises en ophtalmologie et/ou dans la sphere otorhinolaryngologique.
WO1994012460A1 (en) * 1992-12-02 1994-06-09 The Boots Company Plc Process for preparing substantially pure enantiomers of phenylpropionic acids
IT1264855B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici
IT1264856B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica ad attivita' analgesica
IT1266583B1 (it) * 1993-07-30 1997-01-09 Zambon Spa Processo per la preparazione di sali dell'acido 2-(4-isobutilfenil)- propionico
CA2183422A1 (en) * 1994-02-24 1995-08-31 Otsuka Pharmaceutical Factory, Inc. Analgesic activity enhancer
ES2105948B1 (es) * 1994-10-31 1998-07-01 Zambon Spa Procedimiento para la preparacion de sales de acido 2-(4-isobutilfenil) propionico.
US7914814B2 (en) 1997-09-17 2011-03-29 Strategic Science & Technologies, Llc Topical delivery of arginine of cause beneficial effects
EP2158907B1 (de) * 1997-09-17 2015-08-05 Strategic Science & Technologies, LLC Topische Arginin-Verabreichung zur Schmerzbehandlung
KR100523242B1 (ko) * 2000-05-18 2005-10-24 한미약품 주식회사 이부프로펜을 함유하는 정제 조성물
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
AU2005235309B2 (en) 2004-04-19 2012-07-26 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
ES2303468B1 (es) * 2007-01-22 2009-06-08 Masterfarm, S.L "una composicion farmaceutica pulverulenta que comprende ibuprofeno".
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
EP2445492B1 (de) 2009-06-24 2016-09-28 Strategic Science & Technologies, LLC Topische zusammensetzung mit ibuprofen
US12138268B2 (en) 2009-06-24 2024-11-12 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
WO2010151241A1 (en) 2009-06-24 2010-12-29 Strategic Science & Technologies, Llc Topical composition containing naproxen
CN101978955A (zh) * 2010-11-05 2011-02-23 航天中心医院 右旋布洛芬氨基酸盐片剂及其制备方法
CN105878172A (zh) 2010-12-29 2016-08-24 战略科学与技术有限责任公司 治疗变态反应和其它适应症的系统和方法
EP2658551B1 (de) 2010-12-29 2020-07-01 Strategic Science & Technologies, LLC Behandlung von erektionsstörungen und anderen indikationen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH377368A (de) * 1960-04-07 1964-05-15 Inventa Ag Verfahren zur Reinigung von 1(+)-Lysin
IT1059677B (it) * 1974-03-22 1982-06-21 Neopharmed Spa Sale di lisina ad azione terapeutica
EP0267321B1 (de) * 1986-11-14 1990-02-28 MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG Ibuprofen enthaltendes Arzneimittel
US4851444A (en) * 1987-07-10 1989-07-25 Analgesic Associates Onset-hastened/enhanced analgesia

Also Published As

Publication number Publication date
AU635074B2 (en) 1993-03-11
AU6469290A (en) 1991-04-26
PT95564A (pt) 1991-08-14
DK0424028T3 (da) 1996-01-29
IE68508B1 (en) 1996-06-26
DE69022678T2 (de) 1996-03-21
EP0424028A2 (de) 1991-04-24
IE903717A1 (en) 1991-04-24
JPH03206064A (ja) 1991-09-09
EP0424028A3 (en) 1992-06-10
CA2027624A1 (en) 1991-04-18
KR910007858A (ko) 1991-05-30
DE69022678D1 (de) 1995-11-02
EP0424028B1 (de) 1995-09-27
PT95564B (pt) 1997-11-28

Similar Documents

Publication Publication Date Title
ATE128452T1 (de) S(+)-ibuprofen-l-aminosäure und s(+)-ibuprofen-d- aminosäure als analgetika mit grösserem pharmakologischem potential.
DE69013913D1 (de) Herstellung von cyanidhaltigen perfluorpolymeren mit iodatomen als vernetzungsstellen.
DK0413528T3 (da) Amphotere præparater og polymere former af alphahydroxysyrer og deres terapeutiske anvendelse
LU90710I2 (fr) Galanthamine ou ses sels d'addition acides
PT96021A (pt) Metodo de tratamento de doencas utilizando potenciadores de fluxo transdermico tais como acido e 1-dodecilazacicloheptan-2-ona em combinacao com iontoforese na administracao topica de agentes farmaceuticos
PT727210E (pt) Agente analgesico e sua utilizacao
ATE32730T1 (de) Indikatormarkierte konjugate von metallothionein und zielsuchenden, biologisch aktiven molekuelen.
DE69025626D1 (de) Spritzgiessen von kreuzgelegten laminaten
KR910002005A (ko) 바이폴라트랜지스터와 그 제조방법
DE69314077D1 (de) Herstellung von Oxid-Supraleitern mit grosser magnetischer Schwebekraft
YU108691A (sh) Nove 3,3'-ditiobis (propionske kiseline) i njihovi estri
BR8903812A (pt) Transitor bipolar e metodo de formacao do mesmo
ATE99310T1 (de) Substituierte 1,8-naphthyridine.
ATE91689T1 (de) Geminale bisphosphonsaeuren und deren derivate als antiarthritische mittel.
DE69029089D1 (de) Schneller Nachweis des Haar-pH-Wertes und dazugehörige Lösung
ES2072869T3 (es) Uso de derivados de la 1,4-dihidropiridina en el tratamiento del alcoholismo.
NO942531L (no) Fremgangsmåte for fremstilling av 3-acylöstratriener og acylbenzener
BR9007019A (pt) Aplicacao de esteres polioxialquilicos de acidos monocarboxilicos como agentes de tratamento de texteis pouco espumantes
ES1006941Y (es) Bola de petanca.
ATE119940T1 (de) Gewebs-plasminogen-aktivator-derivat.
FR2647301B1 (fr) Variete de pinus nigra nain brepo
UA7730A1 (uk) Засіб одержання складного етілового ефіра аповінкамінової кислоти
FI915606A7 (fi) Sulatteen käsittely kaasulla ja laite sitä varten
DE3750601D1 (de) XY-Anzeigeeinrichtung mit Übergangsintensitätssteuerung.
KR910001144A (ko) 바이폴라소자 및 그 제조방법

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee